SYRE
SYRE
NASDAQ · Biotechnology

Spyre Therapeutics Inc

$90.27
-2.41 (-2.60%)
As of Sep 21, 1:30 PM ET ·
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Buy 21 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target -12.6% upside
Low Target $58.92
Average Target $78.92
High Target $128.60
Current Price $90.27
Current
$90.27
Target
$78.92
$58.92 $78.92 avg $128.60
Scenario Analysis
Bear Case
$58.92
-34.7%
Low target
Base Case
$78.92
-12.6%
Avg target
Bull Case
$128.60
+42.5%
High target
Risk/Reward
1.2x
Balanced
Price in Context
52-Week High
$110.18
-18.1% from high
52-Week Low
$14.51
+522.3% from low
50-Day SMA
$33.24
+171.6% vs SMA
200-Day SMA
$22.06
+309.2% vs SMA
RSI (14)
64.7
Neutral
Target vs 52W High
$78.92
-28.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.7%
AMGN
Amgen Inc
Hold 43 47% $190.87 -51.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.3%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.3%
MRNA
Moderna Inc
Hold 30 37% $149.45 -13.8%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -61.5%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -41.0%